lebrikizumab,cbp-201,rpt193,nemolizumab,etrasimod,cendakimab,amlitelimab sar445229,aslan004,tralokinumab
rapt therapeutics,amgen,pfizer,bms,galderma,eli lilly,sanofi,connect biopharma,aslan pharmaceuticals,astrazeneca,
['derm']
it's great to see so many new therapies on the horizon for #atopicdermatitis ! #aad2023 #aad23 
FRCPC Internal Medicine - Clinical Immunology & Allergy. Lifelong learner, inspired by those around me! Views are my own.⚕️